00:20:14Canada

Processa Pharmaceuticals, Inc. (PCSA)

NASDAQ

Key stats Fiscal year 2025

Income statement

Net income
-13,563,834
Operating income
-13,988,505
Earnings per share
-10.36

Growth and profitability

Return on equity
-243.20
Return on assets
-173.59

Balance sheet

Total assets
7,813,567
Total liabilities
2,236,253
Shareholders' equity
5,577,314
Cash and equivalents
5,536,955
Current ratio
2.54

Cash flow and ratios

Operating cash flow
-11,385,195

Shareholder returns

Shares outstanding
2,798,241
Book value per share
1.99
Revenue and net income
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Vero Beach, FL
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

Processa Pharmaceuticals, Inc. trades on NASDAQ under the ticker symbol PCSA. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis